Lisanti Capital Growth, LLC Castle Biosciences Inc Transaction History

Lisanti Capital Growth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$39.06 - $67.58 $1.4 Million - $2.42 Million	-35,855 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$60.13 - $77.6 $4.32 Million - $5.57 Million	-71,795 Reduced 66.69%	35,855 $2.38 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $2.53 Million - $3.88 Million	50,470 Added 88.27%	107,650 $7.89 Million
Q1 2021 May 12, 2021	BUY	$58.92 - $97.33 $3.37 Million - $5.57 Million	57,180 New	57,180 $3.92 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.